Trials / Recruiting
RecruitingNCT06991972
Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients
Puncture to Repigment: A Comparative Analysis Of Needling vs. Microneedling Along With NBUVB in Treatment of Non-Segmental Vitiligo
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Khyber Teaching Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.
Detailed description
The study will enroll 80 patients aged 15-60 years with localized stable vitiligo. Participants will be randomized into two groups: one receiving needling and the other microneedling, each followed by NBUVB therapy. The primary outcome is the percentage of repigmentation at 12 weeks, assessed through digital planimetry and standardized clinical photography. Secondary outcomes include adverse effects such as erythema, post-inflammatory hyperpigmentation, infection, and scarring.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Needling + NBUVB | Participants in this arm will undergo needling using a sterile 30G (4mm) needle to manually puncture and implant melanocytes from perilesional pigmented skin into depigmented lesions. The procedure will be performed once every four weeks for a total of six sessions. |
| PROCEDURE | Microneedling + NBUVB | Participants in this arm will undergo microneedling using a Dermapen device with 1.5 mm needles to create controlled micro-injuries in depigmented skin to enhance melanocyte migration and repigmentation. This procedure will be performed once every four weeks for six sessions. |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
- First posted
- 2025-05-28
- Last updated
- 2025-09-02
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06991972. Inclusion in this directory is not an endorsement.